The Royal Marsden

Sutton, Surrey SM2 5PT

1 studies enrolling now · 2 studies all time

What they study most

Acute Myeloid Leukemia, HER2 Positive Breast Cancer, Haematological Malignancy, Higher-risk Myelodysplastic Syndrome, Multiple Myeloma, Non Hodgkin Lymphoma, Peripheral T Cell Lymphoma

Studies at this site

• Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies — Recruiting now
• A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast Cancer — Running, not enrolling